Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

AML Care: Good News from SEER database

Change in early death, median survivals

Patients with acute myeloid leukemia (AML) are living almost 4 times longer than they did in the 1970s, with a 3-fold drop in 1-month mortality rates, according to an analysis of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database.

Researchers examined 1-month mortality rates and median survival for 9,380 patients ages 65 and younger who were diagnosed with AML and treated with chemotherapy between 1973 and 2010 and found:

1-month mortality

Median survival



6 months



23 months

Citation: Percival ME, Tao L, Medeiros BC, Clarke CA. Improvements in the early death rate among 9,380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis. Cancer. 2015. doi: 10.1002/cncr.29319.

This Week's Must Reads

CMS freezing of risk adjustment payments predicted to drive up insurance premiums, United States District Court Ruling Puts Risk Adjustment On Hold

If confirmed as Supreme Court justice, Kavanaugh could upend ACA, Case references, including Seven-Sky v. Holder

Software boosts accuracy of colonoscopies, Tripathi PV et al. DDW 2018 (Digestive Disease Week, 2018). Presentation 133.

Proposed fee schedule for 2019 could cut EHR hours,

Must Reads in Leukemia, Myelodysplasia, Transplantation

Added pomalidomide reduced risk of progression, death in myeloma, Richardson PG et al. ASCO 2018, Abstract 8001.

Predicting CLL Prognosis, Can sequencing identify prognostic markers?

Genes Linked to Better Outcomes in AML , SWOG study identifies mutation linked to improved survival

AML Care: Good News from SEER database, Change in early death, median survivals